| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.3B | $0.5B | $0.3B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $0.2B | $0.4B | $0.6B | $1.1B | $1.1B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-0.3B | $-0.6B | $-0.9B | $-2.2B | $-1.8B |
| Net Income | $-0.3B | $-0.5B | $-0.9B | $-2.1B | $-1.8B |
| EPS (Basic) | $-5.64 | $-10.54 | $-0.46 | $-1.25 | $-1.35 |
| EPS (Diluted) | $-5.64 | $-10.54 | $-0.46 | $-1.25 | $-1.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $1.1B | $1.4B | $1.7B | $2.5B | $2.1B |
| Current Assets | $0.5B | $0.6B | $1.0B | $1.5B | $1.7B |
| Cash & Equivalents | $0.2B | $0.6B | $0.9B | $1.3B | $1.6B |
| Total Liabilities | $0.6B | $0.7B | $0.6B | $0.8B | $0.5B |
| Current Liabilities | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Stockholders' Equity | $0.5B | — | — | $1.7B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $-0.3B | $-0.3B | $-0.3B | $-0.3B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $0.0B | $-0.0B | $-0.0B | $0.1B | $1.5B |